{"id":50,"date":"2017-01-29T15:08:54","date_gmt":"2017-01-29T15:08:54","guid":{"rendered":"http:\/\/xn--nrdiagnosenerbrystkrft-o5b7b.dk\/?page_id=50"},"modified":"2017-01-29T15:08:54","modified_gmt":"2017-01-29T15:08:54","slug":"kapitel-3","status":"publish","type":"page","link":"https:\/\/xn--nrdiagnosenerbrystkrft-o5b7b.dk\/index.php\/noter\/kapitel-3\/","title":{"rendered":"Kapitel 3"},"content":{"rendered":"

[237]<\/a> http:\/\/www.dbcg.dk\/PDF%20Filer\/Kap_1_DBCG_15.06.11.pdf<\/a><\/p>\n

[238]<\/a> M\u00f8ller et al. Acta Oncol 2008; 47:506. http:\/\/www.regioner.dk<\/a><\/p>\n

[239]<\/a> Paul Kristjansen Kr\u00e6ft \u2013 Hvad er det. <\/em>Nyt Nordisk Forlag 2001<\/p>\n

[240]<\/a> www.cancer.dk<\/a><\/p>\n

[241]<\/a> http:\/\/www.netdoktor.dk<\/a><\/p>\n

[242]<\/a> http:\/\/www.cancer.dk<\/a><\/p>\n

[243]<\/a> “New studies on surgical options in inherited breast cancer show drastic treatment is not always best.” March 26th, 2010. www.physorg.com<\/a><\/p>\n

[244]<\/a> Abstract 7N.Additional source: European Breast Cancer ConferenceSource reference: Heemskerk-Gerritsen BAM, et al “Is risk-reducing mastectomy in BRCA1\/2 mutation carriers with a history of unilateral breast cancer beneficial with respect to distant disease free survival and overall survival?” EBCC 2010; Abstract 500. http:\/\/www.breastcancer.org<\/a><\/p>\n

[245]<\/a> European Breast Cancer Conference Source reference: Pierce L, et al “Local therapy options in BRCA1\/2 carriers with operable breast cancer: the importance of adjuvant chemotherapy” EBCC 2010; http:\/\/www.breastcancer.org<\/a><\/p>\n

[246]<\/a> Bird NC, Mangnall D, Majeed AW. Biology of colorectal liver metastases: A review. J SurgOncol. 2006 Jul 1;94(1):68-80.<\/p>\n

[247]<\/a> HerbermanRB, Ortaldo JR. Natural killer cells: their roles in defenses against disease. Science. 1981 Oct 2;214(4516):24-30.<\/p>\n

[248]<\/a> MccoyJL, Rucker R, Petros JA. Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status. Breast Cancer Res Treat. 2000 Apr;60(3):227-34.<\/p>\n

[249]<\/a> Da Costa ML, Redmond P, Bouchier-Hayes DJ. The effect of laparotomy and laparoscopy on the establishment of spontaneous tumor metastases. Surgery. 1998 Sep;124(3):516-25.<\/p>\n

Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann SurgOncol. 2003 Oct;10(8):972-92.<\/p>\n

McCulloch PG, MacIntyre A. Effects of surgery on the generation of lymphokine-activated killer cells in patients with breast cancer. Br J Surg. 1993 Aug;80(8):1005-7.<\/p>\n

Rosenne E, Shakhar G, Melamed R, et al. Inducing a mode of NK-resistance to suppression by stress and surgery: a potential approach based on low dose of poly I-C to reduce postoperative cancer metastasis. Brain Behav Immun. 2007 May;21(4):395-408.<\/p>\n

[250]<\/a> Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann SurgOncol. 2003 Oct;10(8):972-92.<\/p>\n

[251]<\/a> Ribatti D. History of Research on Tumor Angiogenesis. Springer;2009:9.<\/p>\n

Rege TA, Fears CY, Gladson CL. Endogenous inhibitors of angiogenesis in malignant gliomas: nature\u2019s antiangiogenic therapy. NeuroOncol. 2005 Apr;7(2):106-21.<\/p>\n

[252]<\/a> Baum M, Demicheli R, Hrushesky W, et al. Does surgery unfavourably perturb the \u201cnatural history\u201d of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer. 2005 Mar;41(4):508-15.<\/p>\n

Folkman J. Fundamental concepts of the angiogenic process. CurrMol Med. 2003 Nov;3(7):643-51.<\/p>\n

Pinsolle V, Ravaud A, Baudet J. [Does surgery promote the development of metastasis in melanoma?]. Ann ChirPlastEsthet. 2000 Aug;45(4):485-93.<\/p>\n

Raymond E. [Tumor angiogenesis inhibitors: media and scientific aspects]. Presse Med. 1998 Jul 4-11;27(24):1221-4.<\/p>\n

[253]<\/a> Goldfarb Y, Ben-Eliyahu S. Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Dis. 2006-2007;26:99-114.<\/p>\n

Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann SurgOncol. 2003 Oct;10(8):972-92.<\/p>\n

[254]<\/a> van der BijGJ, OosterlingSJ, Beelen RH, et al. The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer. Ann Surg. 2009 May;249(5):727-34.<\/p>\n

[255]<\/a> DowdallJF, Winter DC, Andrews E, et al. Soluble interleukin 6 receptor (sIL-6R) mediates colonic tumor cell adherence to the vascular endothelium: a mechanism for metastatic initiation? J Surg Res. 2002 Sep;107(1):1-6.<\/p>\n

[256]<\/a> Raz A, Lotan R. Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev. 1987;6(3):433-52.<\/p>\n

[257]<\/a> Yu LG, Andrews N, Zhao Q, et al. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J Biol Chem. 2007 Jan 5;282(1):773-81.<\/p>\n

[258]<\/a> Raz A, Lotan R. Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev. 1987;6(3):433-52.<\/p>\n

[259]<\/a> ten Kate M, HoflandLJ, van GrevensteinWM, et al. Influence of proinflammatory cytokines on the adhesion of human colon carcinoma cells to lung microvascular endothelium. Int J Cancer. 2004 Dec 20;112(6):943-50.<\/p>\n

[260]<\/a> Asher ME. Surgical considerations in the elderly. J Perianesth Nurs. 2004 Dec;19(6):406\u201314.<\/p>\n

Schmiesing CA, Brodsky JB. The preoperative anesthesia evaluation. Thorac Surg Clin. 2005 May;15(2):305\u201315.<\/p>\n

[261]<\/a>Patel GK. The role of nutrition in the management of lower extremity wounds. Int J Low Extrem Wounds. 2005a Mar;4(1):12\u201322.<\/p>\n

[262]<\/a> Lambert SA. The effects of hypnosis\/guided imagery on the postoperative course of children. J Dev Behav Pediatr. 1996 Oct;17(5):307\u201310.<\/p>\n

Rapkin DA, Straubing M, et al. Guided imagery, hypnosis and recovery from head and neck cancer surgery: An exploratory study. Int J Clin Exp Hypn. 1991 Oct;39(4):215\u201326.<\/p>\n

[263]<\/a> Halpin LS, Speir AM, et al. Guided imagery in cardiac surgery. Outcomes Manag. 2002 Jul;6(3):132\u20137.<\/p>\n

Norred CL. Minimizing preoperative anxiety with alternative caring-healing therapies. AORN J. 2000 Nov;72(5): 838\u201340, 842\u20133.<\/p>\n

[264]<\/a> Tusek D, Church JM, et al. Guided imagery as a coping strategy for perioperative patients. AORN J. 1997a Oct;66(4):644\u20139.<\/p>\n

Tusek DL, Church JM, et al. Guided imagery: A significant advance in the care of patients undergoing elective colorectal surgery. Dis Colon Rectum. 1997b Feb;40(2):172\u20138.<\/p>\n

[265]<\/a> Luyten CR, van Overveld FJ, et al. Antioxidant defence during cardiopulmonary bypass surgery. Eur J Cardiothorac Surg. 2005 Apr;27(4):611\u20136.<\/p>\n

Schindler R, Berndt S, et al. Plasma vitamin E and A changes during cardiopulmonary bypass and in the postoperative course. Langenbecks Arch Surg. 2003 Jan;387(9-10):372\u20138.<\/p>\n

[266]<\/a> Canbaz S, Duran E, et al. The effects of intracoronary administration of vitamin E on myocardial ischemia-reperfusion injury during coronary artery surgery. Thorac Cardiovasc Surg. 2003 Apr;51(2):57\u201361.<\/p>\n

Xia Z, Gu J, et al. Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease. J Thorac Cardiovasc Surg. 2003 Nov;126(5):1404\u201310.<\/p>\n

[267]<\/a> DeWeese TL, Hruszkewycz AM, et al. Oxidative stress in chemoprevention trials. Urology. 2001 Apr;57(4 Suppl 1):137\u201340.<\/p>\n

[268]<\/a> Michalik L, Wahli W. Involvement of PPAR nuclear receptors in tissue injury and wound repair. J Clin Invest. 2006 Mar;116(3):598\u2013606.<\/p>\n

[269]<\/a> Potts MB, Koh SE, et al. Traumatic injury to the immature brain: Inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets. NeuroRx. 2006 Apr;3(2):143\u201353.<\/p>\n

[270]<\/a> De la Fuente M, Hernanz A, et al. The immune system in the oxidative stress conditions of aging and hypertension: Favorable effects of antioxidants and physical exercise. Antioxid Redox Signal. 2005 Sep;7(9\u201310):1356\u201366.<\/p>\n

[271]<\/a> Stark G. Functional consequences of oxidative membrane damage. J Membr Biol. 2005 May;205(1):1\u201316.<\/p>\n

[272]<\/a> Thurston G, Baluk P, et al. Determinants of endothelial cell phenotype in venules. Microcirculation. 2000 Feb;7(1):67\u201380.<\/p>\n

[273]<\/a> Fall PJ, Szerlip HM. Lactic acidosis: From sour milk to septic shock. J Intensive Care Med. 2005 Sep;20(5):255\u201371.<\/p>\n

[274]<\/a> Antall GF, Kresevic D. The use of guided imagery to manage pain in an elderly orthopaedic population. Orthop Nurs. 2004 Sep;23(5):335\u201340.<\/p>\n

Halpin LS, Speir AM, et al. Guided imagery in cardiac surgery. Outcomes Manag. 2002 Jul;6(3):132\u20137.<\/p>\n

Lambert SA. The effects of hypnosis\/guided imagery on the postoperative course of children. J Dev Behav Pediatr. 1996 Oct;17(5):307\u201310.<\/p>\n

[275]<\/a> Khanna S, Roy S, et al. Upregulation of oxidant-induced VEGF expression in cultured keratinocytes by a grape seed proanthocyanidin extract. Free Radic Biol Med. 2001 Jul 1;31(1):38\u201342.<\/p>\n

Khanna S, Venojarvi M, et al. Dermal wound healing properties of redox-active grape seed proanthocyanidins. Free Radic Biol Med. 2002 Oct 15;33(8):1089\u201396.<\/p>\n

[276]<\/a> Ellis LM, Copeland EM, III, et al. Perioperative nutritional support. Surg Clin North Am. 1991 Jun;71(3):493\u2013507.<\/p>\n

[277]<\/a> Braverman, A.: Medical oncology in the 1990s. Lancet 1991;337:901-902.<\/p>\n

[278]<\/a> https:\/\/www.sundhed.dk<\/a><\/p>\n

[279]<\/a> https:\/\/www.sundhed.dk<\/a><\/p>\n

[280]<\/a> http:\/\/laegehaandbogen.dk<\/a><\/p>\n

[281]<\/a> Alschuler 2007<\/p>\n

[282]<\/a> Forkner, CE: Leukemia and allied disorders. NY: Macmillan 1938.<\/p>\n

[283]<\/a> Pack, GT and Livingstone, EM.: Treatment of cancer and allied diseases, by 147 international authors. NY: Paul B. Hoeber, 1940.<\/p>\n

[284]<\/a> Ward, PS.: American reception of Salvarsan. JHMAS 1981:36.<\/p>\n

[285]<\/a> Stokes, J.:Certain technical requirements in methods of intraveneous injections. Med Rec 1917; 92: 529.<\/p>\n

[286]<\/a> Ehrlich, P.The collected papers of Paul Ehrlich. F. Himmelweit, ed. London: Pergamon, 1956.<\/p>\n

Golomb, FM.: Agents used in cancer chemotherapy. Am J surg 1963; 105:579-590.<\/p>\n

[287]<\/a> Patterson, JT.: The dread disease. Cambridge, MA: Harvard University Press, 1987.<\/p>\n

[288]<\/a> Gilman, A.:The initial clinical trial of nitrogen mustard. Am J Surg 1963; 105: 574-578.<\/p>\n

[289]<\/a> Adair, FE and Bagg, HJ.: Experimental and clinical studies on treatment of cancer by dichloroethylsulfide (mustard gas). Ann Surg 1931;93:190.<\/p>\n

[290]<\/a> Perry, MC and Yarbro, JW.: Toxicity of chemotherapy. Orlando: Grune & Stratton, 1984.<\/p>\n

[291]<\/a> Moss, Ralph W. The Cancer Industry. NY: Paragon, 1989<\/p>\n

[292]<\/a> Israel, L.: Conquering cancer. NY: Random House, 1978.<\/p>\n

[293]<\/a> Bross, ID: The NSABP trials (letter). NEJM 1994; 331:809.<\/p>\n

[294]<\/a> Zobrod, CG.: Chemical control of cancer (based on a National Academy of Sciences symposium held in October 1991). PNAS 1972; 69:1042-1046.<\/p>\n

[295]<\/a> Cairns, J.: The treatment of diseases and the war against cancer. Sci Am 1985; 253:51-59.<\/p>\n

[296]<\/a> Greenberg, D.: Progress in cancer research \u2013 don\u00b4t say it isn\u00b4t so. NEJM 1975; 292: 707-708.<\/p>\n

[297]<\/a> Greenberg, D.: Progress in cancer research \u2013 don\u00b4t say it isn\u00b4t so. NEJM 1975; 292: 707-708.<\/p>\n

[298]<\/a> Illich, I.: Medical nemesis: the expropriation of health. NY: bantam Books 1976<\/p>\n

[299]<\/a> Epstein, SS and rennie, SA.: Travesty at wommen\u00b4s expense. Los Angeles Times 6\/22\/92<\/p>\n

[300]<\/a> Bailar, Jc. III and Smith, E.:Progress against cancer? NEJM 1986; 314: 1226-1232.<\/p>\n

[301]<\/a> A Dull Weapon: Chemotherapy Almost Useless in Treating Advanced Organic Cancer\u2014Provocative Theses at the Hamburg Cancer Congress<\/p>\n

Artikel i Der Spiegel 33\/1990, 174-176 oversat af People Against Cancer, Otho Iowa. Her fra: http:\/\/www.mnwelldir.org\/docs\/fraud\/able.htm 2009<\/a>. Den oprindelige artikel kan l\u00e6ses her: http:\/\/www.spiegel.de\/spiegel\/print\/d-13500786.html<\/a><\/p>\n

[302]<\/a> Abel, U.: Chemotherapy of advanced epithelial cancer: a critical review. Biomedicine & Pharmacotherapy 1992; 46: 439-452<\/p>\n

Abel, U.: Personal communication 5\/16\/94 (med Ralph Moss). Her i Moss, Ralph W.: Questioning Chemotherapy. Equinox 2004<\/p>\n

[303]<\/a> Abel, Ulrich: Cytostatic Therapy of Advanced Epithelial Tumors \u2014 A Critique (Hippocrates Verlag, Stuttgart. 112 pages. 28 marks).<\/p>\n

[304]<\/a> Macaulay, V og Smith, IE.: Advanced Breats Cancer. I: Slevin and Staquet 1986: 273-258.<\/p>\n

[305]<\/a> Shimkin, RJ.:Contrary to Nature (DHEW Publication No. NIH 79-720. Bethesda: NCI, 1979.<\/p>\n

[306]<\/a> Moss, RW.: Big money in new cancer drugs. The Cancer Chronicles 1991: 2: 4-5.<\/p>\n

[307]<\/a> FDA Consumer Memo 73-30, 1973<\/p>\n

[308]<\/a> James, JD et al.: A guide to drug interactions. NY: McGrawHill, 1978.<\/p>\n

Kagan, BM et al.: Spotlight on antimicrobial agents. JAMA 1973; 226: 306-310.<\/p>\n

[309]<\/a> Karnofsky, D.: Cancer chemotherapeutic agents. CA Cancer J Clin 1968; 18: 72-79.<\/p>\n

[310]<\/a> Colvin, OM og Chabner, BA. Alkylating agents. I Chabner, BA og Collins, JM (eds). Cancer chemotherapy: principles and practice. Philadelphia: J.B. Lippincott, 1990: 276-313.<\/p>\n

[311]<\/a> Wittnes, RE og Hubbard, S.: Chemotherapy: the properties and uses of single agents. I: Wittnes, 1991: 66-121.<\/p>\n

[312]<\/a> Von Hoff, DD. et al.: Risk factors for doxorubicin-induced congestive heart failure. Ann Int Med 1979; 91: 710-717.<\/p>\n

[313]<\/a> Moss, Ralph W.: Questioning Chemotherapy. Equinox 2004<\/p>\n

[314]<\/a> Holmes, FA et al.: Phase II trial of taxol: an active drug in metastatic breast cancer. JNCI 1991; 83: 1797-1805.<\/p>\n

[315]<\/a> Rowinsky, EK. et al.: Phase I and pharmacodynamic study of taxol in refractory acute leukemias. JCO 1991; 9: 1704-1712.<\/p>\n

[316]<\/a> Brandwein, MS et al.: Fatal pulmonary lipid embolism associated with taxol therapy. Mt Sinai J Med 1988; 55: 187-189.<\/p>\n

[317]<\/a> J Clin Oncol 1996; 14: 58-65<\/p>\n

[318]<\/a> J Clin Oncol 1999; 17: 2341-54<\/p>\n

[319]<\/a> J Clin Oncol 1999; 17: 2341-54<\/p>\n

[320]<\/a> Moss, Ralph W.: Questioning Chemotherapy. Equinox 2004<\/p>\n

[321]<\/a> http:\/\/www.dagensmedicin.dk\/nyheder\/2006\/11\/29\/intelligente-lagemidler-gor\/<\/a>\u00a0 29-11-2006<\/p>\n

[322]<\/a> J Clin Oncol 1999; 17:485. Her i Moss, Ralph W.: Questioning Chemotherapy. Equinox 2004<\/p>\n

[323]<\/a> Clin Oncol (R Coll Radiol) 2004; 16(8): 549-60. http:\/\/www.naturli.dk\/naturli-viden\/behandling\/10272-kemoterapi-den-helt-almindelige-gift<\/a><\/p>\n

[324]<\/a> http:\/\/ing.dk\/artikel\/720-danskere-udsaettes-arligt-virkningslos-smertelig-kemoterapi-93581<\/a><\/p>\n

[325]<\/a> http\/\/:www.naturli\/helsenyt\/8273-kemoterapi-gavner-kun-hver-10-kvinde\/<\/p>\n

[326]<\/a> Sun, Y., Campisi, J., Higano, C., Beer, T.M., Porter, P., Coleman, I., True, L. & Nelson, P.S. (2012). Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B, Nature Medicine, <\/em>DOI: 10.1038\/nm.2890<\/a> http:\/\/www.dagensmedicin.dk\/videnskab\/cancer\/kemoterapi-stimulerer-cellevakst-og-gor-krafttumorer-resistente\/<\/a> Opdateret 22.08.2012<\/em>\u00a0Videnskab: Cancer<\/em>
\nhttp:\/\/scienceblog.cancerresearchuk.org\/2012\/08\/06\/headlines-about-backfiring-chemotherapy-are-misleading\/<\/a><\/p>\n

[327]<\/a> Early breast cancer trialist\u00b4s collaborative group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365:1687-717.<\/p>\n

[328]<\/a> Mouridsen HT, Robert NJ. The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women. Eur J Cancer 2005;41:1678-89. http:\/\/www.irf.dk\/dk\/publikationer\/rationel_farmakoterapi\/maanedsblad\/2006\/medikamentel_behandling_af_brystkraeft.htm<\/a><\/p>\n

[329]<\/a> http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1760730\/<\/a><\/p>\n

[330]<\/a> http:\/\/www.breastcancer.org\/research-news\/ovary-suppression-w-aromasin-better-than-w-tamoxifen<\/a><\/p>\n

[331]<\/a> http:\/\/www.farma.ku.dk\/index.php\/Haab-om-bedre-behandling-af-br\/1591\/0\/<\/a><\/p>\n

[332]<\/a> Nakagawa, T. et al.: Angiology, vol. 45 s. 333 Maj 1994. Her i: Quillin 2005<\/p>\n

[333]<\/a> Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88.
\nPavlidis, NA. Et al.: Cancer, vol. 69 s. 2961. 1992. Her i: Quillin 2005<\/p>\n

[334]<\/a> Harris JRMMNL. Malignant tumors of the breast.1997( Section 2).
\nCuzick J, Powles T, Veronesi U, Overview of the main outcomes in breast-cancer prevention trials. Lancet 2003;361(9354):296-300. http:\/\/www.irf.dk\/dk\/publikationer\/rationel_farmakoterapi\/maanedsblad\/2006\/medikamentel_behandling_af_brystkraeft.htm<\/a><\/p>\n

[335]<\/a> Fornander, T et al.: Effects of tamoxifen on the female genital tract. Ann NY Acad Sci 191; 622: 469-476.<\/p>\n

[336]<\/a> Moss, Ralph W.: Questioning Chemotherapy. Equinox 2004<\/p>\n

[337]<\/a> Veronesi, U., P. Maisonneuve, . Costa, V. Sacchini et al.: Prevention of Breast Cancer with Tamoxifen: preliminary Findings from the Italian randomized Trial among Hysterectomized Women. The Lancet 352 (1998): 93-97<\/p>\n

[338]<\/a> The Lancet 2002; 360: 817-24). http:\/\/radiodoktoren.dk\/radiodoktoren\/2010\/11\/06\/tamoxifen-2<\/a><\/p>\n

[339]<\/a> Singer CF, Hudelist G, Schreiber M, Kubista E. Pharmacological modulation of IGF serum concentrations as a therapeutic approach to control the growth of malignant breast tumors. Drugs Today (Barc). 2003 Feb;39(2):115-25.<\/p>\n

Lee AV, Weng CN, Jackson JG, Yee D. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells. J Endocrinol. 1997 Jan;152(1):39-47.<\/p>\n

[340]<\/a> Publiceret i september nummeret\u00a0 2012 af PLoS One.<\/p>\n

www.dagensapotek.se<\/a><\/p>\n

[341]<\/a> www.skane.se\/sv\/Webbplatser\/Skanes-universitetssjukhus\/Nyheter\/Arkiv\/Nyheter-2013\/Sara-har-tagit-ett-steg-narmara-skraddersydd-cancerbehandling\/<\/a><\/p>\n

[342]<\/a> Cancer 1998; 83:1142-1152.<\/p>\n

[343]<\/a> http:\/\/min.medicin.dk\/Medicin\/Praeparater\/1220<\/a><\/p>\n

[344]<\/a> Oncology 1998; 12S: 41-4. Her i Moss, Ralph W.: Questioning Chemotherapy. Equinox 2004<\/p>\n

[345]<\/a> http:\/\/www.netdoktor.dk<\/p>\n

[346]<\/a> American Association for Cancer Research. “Aromatase inhibitors increase risk of heart disease in postmenopausal women with breast cancer, analysis finds.” ScienceDaily. ScienceDaily, 9 December 2010.<\/p>\n

[347]<\/a> Semin Oncol 1999; 26S: 89-95.<\/p>\n

[348]<\/a> Semin Oncol 1999; 26S: 78-83<\/p>\n

[349]<\/a> Tan-Chiu E, Yothers G, Romond E, Geyer CE, Ewer M, et al. Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31. J Clin Oncol (2005) 23: 7811-7819.<\/p>\n

http:\/\/www.irf.dk\/dk\/publikationer\/rationel_farmakoterapi\/maanedsblad\/2006\/medikamentel_behandling_af_brystkraeft.htm<\/a><\/p>\n

[350]<\/a> Tobias JS. Clinical practice of radiotherapy. Lancet. 1992;339(8786):159-63.<\/p>\n

[351]<\/a> Emami B, Lyman J, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109-22.<\/p>\n

[352]<\/a> Burnet NG, Wurm R, et al. Normal tissue radiosensitivity–how important is it? Clin Oncol (R Coll Radiol). 1996;8(1):25-34.<\/p>\n

[353]<\/a> Dunne-Daly CF. Principles of radiotherapy and radiobiology. Semin Oncol Nurs. 1999;15(4):250-9.<\/p>\n

[354]<\/a> Ross GM. Induction of cell death by radiotherapy. Endocr Relat Cancer. 1999;6(1):41-4.<\/p>\n

[355]<\/a> Kerr JF, Winterford CM, et al. Apoptosis. Its significance in cancer and cancer therapy. Cancer. 1994;73(8):2013-26.<\/p>\n

[356]<\/a> Fang YZ, Yang S, et al. Free radicals, antioxidants, and nutrition. Nutrition. 2002;18(10):872-9.<\/p>\n

[357]<\/a> Mates JM, Sanchez-Jimenez FM. Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int J Biochem Cell Biol. 2000;32(2):157-70.<\/p>\n

[358]<\/a> Hoskin PJ, Price P, et al. A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol. 1992;23(2):74-8.<\/p>\n","protected":false},"excerpt":{"rendered":"

[237] http:\/\/www.dbcg.dk\/PDF%20Filer\/Kap_1_DBCG_15.06.11.pdf [238] M\u00f8ller et al. Acta Oncol 2008; 47:506. http:\/\/www.regioner.dk [239] Paul Kristjansen Kr\u00e6ft \u2013 Hvad er det. Nyt Nordisk Forlag 2001 [240] www.cancer.dk [241] http:\/\/www.netdoktor.dk [242] http:\/\/www.cancer.dk [243] “New studies on surgical options in inherited breast cancer show … L\u00e6s resten →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":27,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-50","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/xn--nrdiagnosenerbrystkrft-o5b7b.dk\/index.php\/wp-json\/wp\/v2\/pages\/50","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xn--nrdiagnosenerbrystkrft-o5b7b.dk\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/xn--nrdiagnosenerbrystkrft-o5b7b.dk\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/xn--nrdiagnosenerbrystkrft-o5b7b.dk\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/xn--nrdiagnosenerbrystkrft-o5b7b.dk\/index.php\/wp-json\/wp\/v2\/comments?post=50"}],"version-history":[{"count":1,"href":"https:\/\/xn--nrdiagnosenerbrystkrft-o5b7b.dk\/index.php\/wp-json\/wp\/v2\/pages\/50\/revisions"}],"predecessor-version":[{"id":51,"href":"https:\/\/xn--nrdiagnosenerbrystkrft-o5b7b.dk\/index.php\/wp-json\/wp\/v2\/pages\/50\/revisions\/51"}],"up":[{"embeddable":true,"href":"https:\/\/xn--nrdiagnosenerbrystkrft-o5b7b.dk\/index.php\/wp-json\/wp\/v2\/pages\/27"}],"wp:attachment":[{"href":"https:\/\/xn--nrdiagnosenerbrystkrft-o5b7b.dk\/index.php\/wp-json\/wp\/v2\/media?parent=50"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}